nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.102	0.197	CbGbCtD
Zolmitriptan—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0958	0.185	CbGbCtD
Zolmitriptan—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0958	0.185	CbGbCtD
Zolmitriptan—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0866	0.167	CbGbCtD
Zolmitriptan—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0726	0.14	CbGbCtD
Zolmitriptan—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0656	0.127	CbGbCtD
Zolmitriptan—MAOA—nerve—acquired immunodeficiency syndrome	0.00322	0.0876	CbGeAlD
Zolmitriptan—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00267	0.0725	CbGeAlD
Zolmitriptan—MAOA—blood plasma—acquired immunodeficiency syndrome	0.00244	0.0663	CbGeAlD
Zolmitriptan—HTR1F—nervous system—acquired immunodeficiency syndrome	0.0024	0.0652	CbGeAlD
Zolmitriptan—HTR1F—central nervous system—acquired immunodeficiency syndrome	0.00231	0.0628	CbGeAlD
Zolmitriptan—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00203	0.0553	CbGeAlD
Zolmitriptan—HTR1F—brain—acquired immunodeficiency syndrome	0.00183	0.0499	CbGeAlD
Zolmitriptan—MAOA—retina—acquired immunodeficiency syndrome	0.00133	0.0363	CbGeAlD
Zolmitriptan—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00117	0.0317	CbGeAlD
Zolmitriptan—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000983	0.0267	CbGeAlD
Zolmitriptan—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000951	0.0259	CbGeAlD
Zolmitriptan—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000946	0.0257	CbGeAlD
Zolmitriptan—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000941	0.0256	CbGeAlD
Zolmitriptan—MAOA—digestive system—acquired immunodeficiency syndrome	0.000937	0.0255	CbGeAlD
Zolmitriptan—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000916	0.0249	CbGeAlD
Zolmitriptan—MAOA—blood—acquired immunodeficiency syndrome	0.000892	0.0243	CbGeAlD
Zolmitriptan—MAOA—spinal cord—acquired immunodeficiency syndrome	0.00086	0.0234	CbGeAlD
Zolmitriptan—MAOA—vagina—acquired immunodeficiency syndrome	0.000827	0.0225	CbGeAlD
Zolmitriptan—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000793	0.0216	CbGeAlD
Zolmitriptan—MAOA—lung—acquired immunodeficiency syndrome	0.000782	0.0213	CbGeAlD
Zolmitriptan—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000781	0.0213	CbGeAlD
Zolmitriptan—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000763	0.0208	CbGeAlD
Zolmitriptan—HTR1B—brain—acquired immunodeficiency syndrome	0.000751	0.0204	CbGeAlD
Zolmitriptan—CYP1A2—blood—acquired immunodeficiency syndrome	0.000744	0.0203	CbGeAlD
Zolmitriptan—HTR1D—brain—acquired immunodeficiency syndrome	0.000727	0.0198	CbGeAlD
Zolmitriptan—MAOA—nervous system—acquired immunodeficiency syndrome	0.000724	0.0197	CbGeAlD
Zolmitriptan—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000697	0.019	CbGeAlD
Zolmitriptan—CYP1A2—lung—acquired immunodeficiency syndrome	0.000653	0.0178	CbGeAlD
Zolmitriptan—HTR1A—brain—acquired immunodeficiency syndrome	0.000606	0.0165	CbGeAlD
Zolmitriptan—HTR1F—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000575	0.0187	CbGpPWpGaD
Zolmitriptan—MAOA—brain—acquired immunodeficiency syndrome	0.000554	0.0151	CbGeAlD
Zolmitriptan—MAOA—lymph node—acquired immunodeficiency syndrome	0.000535	0.0146	CbGeAlD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000483	0.0157	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000473	0.0153	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000457	0.0149	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000442	0.0144	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000414	0.0134	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000368	0.0119	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00036	0.0117	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00036	0.0117	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000348	0.0113	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000321	0.0104	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000315	0.0102	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000302	0.00981	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000302	0.00981	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000298	0.00968	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000295	0.00958	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000292	0.0095	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000286	0.0093	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000282	0.00917	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00028	0.00911	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000274	0.0089	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000264	0.00859	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000259	0.00841	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000255	0.0083	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00024	0.0078	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00024	0.0078	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00023	0.00746	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000223	0.00723	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000218	0.00708	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000218	0.00708	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000215	0.00699	CbGpPWpGaD
Zolmitriptan—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000516	CcSEcCtD
Zolmitriptan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000214	0.000516	CcSEcCtD
Zolmitriptan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000214	0.000516	CcSEcCtD
Zolmitriptan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000213	0.000515	CcSEcCtD
Zolmitriptan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000213	0.000514	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000514	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000513	CcSEcCtD
Zolmitriptan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000513	CcSEcCtD
Zolmitriptan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000513	CcSEcCtD
Zolmitriptan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000513	CcSEcCtD
Zolmitriptan—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000511	CcSEcCtD
Zolmitriptan—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000511	CcSEcCtD
Zolmitriptan—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00051	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00021	0.000508	CcSEcCtD
Zolmitriptan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00021	0.000507	CcSEcCtD
Zolmitriptan—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000507	CcSEcCtD
Zolmitriptan—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000507	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000506	CcSEcCtD
Zolmitriptan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000506	CcSEcCtD
Zolmitriptan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000505	CcSEcCtD
Zolmitriptan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000503	CcSEcCtD
Zolmitriptan—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000503	CcSEcCtD
Zolmitriptan—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000503	CcSEcCtD
Zolmitriptan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.000502	CcSEcCtD
Zolmitriptan—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000502	CcSEcCtD
Zolmitriptan—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000502	CcSEcCtD
Zolmitriptan—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000501	CcSEcCtD
Zolmitriptan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.0005	CcSEcCtD
Zolmitriptan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.0005	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000207	0.00672	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000207	0.000499	CcSEcCtD
Zolmitriptan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000499	CcSEcCtD
Zolmitriptan—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000499	CcSEcCtD
Zolmitriptan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000206	0.000498	CcSEcCtD
Zolmitriptan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000206	0.000498	CcSEcCtD
Zolmitriptan—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000497	CcSEcCtD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000205	0.00667	CbGpPWpGaD
Zolmitriptan—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000496	CcSEcCtD
Zolmitriptan—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000496	CcSEcCtD
Zolmitriptan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000495	CcSEcCtD
Zolmitriptan—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000495	CcSEcCtD
Zolmitriptan—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000494	CcSEcCtD
Zolmitriptan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000494	CcSEcCtD
Zolmitriptan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000494	CcSEcCtD
Zolmitriptan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000494	CcSEcCtD
Zolmitriptan—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000492	CcSEcCtD
Zolmitriptan—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000492	CcSEcCtD
Zolmitriptan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000203	0.00049	CcSEcCtD
Zolmitriptan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000489	CcSEcCtD
Zolmitriptan—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000488	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000201	0.00654	CbGpPWpGaD
Zolmitriptan—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000486	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000201	0.00653	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000485	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000484	CcSEcCtD
Zolmitriptan—Shock—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000484	CcSEcCtD
Zolmitriptan—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000483	CcSEcCtD
Zolmitriptan—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000483	CcSEcCtD
Zolmitriptan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000483	CcSEcCtD
Zolmitriptan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0002	0.000483	CcSEcCtD
Zolmitriptan—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000482	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000481	CcSEcCtD
Zolmitriptan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000199	0.000481	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000481	CcSEcCtD
Zolmitriptan—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000481	CcSEcCtD
Zolmitriptan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00048	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00048	CcSEcCtD
Zolmitriptan—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000479	CcSEcCtD
Zolmitriptan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000198	0.000479	CcSEcCtD
Zolmitriptan—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000478	CcSEcCtD
Zolmitriptan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000477	CcSEcCtD
Zolmitriptan—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000477	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000197	0.00641	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000197	0.0064	CbGpPWpGaD
Zolmitriptan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000475	CcSEcCtD
Zolmitriptan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000475	CcSEcCtD
Zolmitriptan—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000475	CcSEcCtD
Zolmitriptan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.000475	CcSEcCtD
Zolmitriptan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.000475	CcSEcCtD
Zolmitriptan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000474	CcSEcCtD
Zolmitriptan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000196	0.000474	CcSEcCtD
Zolmitriptan—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000473	CcSEcCtD
Zolmitriptan—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000473	CcSEcCtD
Zolmitriptan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000196	0.000472	CcSEcCtD
Zolmitriptan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000471	CcSEcCtD
Zolmitriptan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000471	CcSEcCtD
Zolmitriptan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000471	CcSEcCtD
Zolmitriptan—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00047	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000195	0.00632	CbGpPWpGaD
Zolmitriptan—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000469	CcSEcCtD
Zolmitriptan—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000469	CcSEcCtD
Zolmitriptan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000468	CcSEcCtD
Zolmitriptan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000194	0.000467	CcSEcCtD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000193	0.00627	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000193	0.00627	CbGpPWpGaD
Zolmitriptan—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000466	CcSEcCtD
Zolmitriptan—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000465	CcSEcCtD
Zolmitriptan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000465	CcSEcCtD
Zolmitriptan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000465	CcSEcCtD
Zolmitriptan—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000464	CcSEcCtD
Zolmitriptan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000192	0.000464	CcSEcCtD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000192	0.00624	CbGpPWpGaD
Zolmitriptan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000463	CcSEcCtD
Zolmitriptan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000192	0.000463	CcSEcCtD
Zolmitriptan—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000462	CcSEcCtD
Zolmitriptan—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000461	CcSEcCtD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000191	0.00619	CbGpPWpGaD
Zolmitriptan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.00046	CcSEcCtD
Zolmitriptan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.00046	CcSEcCtD
Zolmitriptan—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00046	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000459	CcSEcCtD
Zolmitriptan—Rash—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000459	CcSEcCtD
Zolmitriptan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000458	CcSEcCtD
Zolmitriptan—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000458	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000458	CcSEcCtD
Zolmitriptan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.000457	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000189	0.00614	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000189	0.00614	CbGpPWpGaD
Zolmitriptan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000189	0.000456	CcSEcCtD
Zolmitriptan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000189	0.000456	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000189	0.00613	CbGpPWpGaD
Zolmitriptan—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000455	CcSEcCtD
Zolmitriptan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000455	CcSEcCtD
Zolmitriptan—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000455	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000454	CcSEcCtD
Zolmitriptan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000454	CcSEcCtD
Zolmitriptan—Rash—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000452	CcSEcCtD
Zolmitriptan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000452	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000451	CcSEcCtD
Zolmitriptan—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000451	CcSEcCtD
Zolmitriptan—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000451	CcSEcCtD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000187	0.00606	CbGpPWpGaD
Zolmitriptan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000186	0.000449	CcSEcCtD
Zolmitriptan—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000449	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000448	CcSEcCtD
Zolmitriptan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000185	0.000448	CcSEcCtD
Zolmitriptan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000447	CcSEcCtD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000185	0.006	CbGpPWpGaD
Zolmitriptan—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000445	CcSEcCtD
Zolmitriptan—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000444	CcSEcCtD
Zolmitriptan—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000443	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000442	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000183	0.00594	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000183	0.00594	CbGpPWpGaD
Zolmitriptan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000442	CcSEcCtD
Zolmitriptan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000441	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000183	0.00593	CbGpPWpGaD
Zolmitriptan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000439	CcSEcCtD
Zolmitriptan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000439	CcSEcCtD
Zolmitriptan—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000439	CcSEcCtD
Zolmitriptan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000438	CcSEcCtD
Zolmitriptan—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000438	CcSEcCtD
Zolmitriptan—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000437	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000436	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000181	0.00587	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000435	CcSEcCtD
Zolmitriptan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00018	0.000434	CcSEcCtD
Zolmitriptan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000433	CcSEcCtD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000179	0.00582	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000433	CcSEcCtD
Zolmitriptan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.000433	CcSEcCtD
Zolmitriptan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000179	0.000432	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000179	0.0058	CbGpPWpGaD
Zolmitriptan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000431	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000178	0.00579	CbGpPWpGaD
Zolmitriptan—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.00043	CcSEcCtD
Zolmitriptan—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000428	CcSEcCtD
Zolmitriptan—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000427	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000177	0.00575	CbGpPWpGaD
Zolmitriptan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000176	0.000426	CcSEcCtD
Zolmitriptan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000425	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000425	CcSEcCtD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000176	0.0057	CbGpPWpGaD
Zolmitriptan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000422	CcSEcCtD
Zolmitriptan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000422	CcSEcCtD
Zolmitriptan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000422	CcSEcCtD
Zolmitriptan—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000421	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000174	0.00566	CbGpPWpGaD
Zolmitriptan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00042	CcSEcCtD
Zolmitriptan—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00042	CcSEcCtD
Zolmitriptan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00042	CcSEcCtD
Zolmitriptan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00042	CcSEcCtD
Zolmitriptan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.000418	CcSEcCtD
Zolmitriptan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000417	CcSEcCtD
Zolmitriptan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000416	CcSEcCtD
Zolmitriptan—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000411	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000411	CcSEcCtD
Zolmitriptan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000409	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000409	CcSEcCtD
Zolmitriptan—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000408	CcSEcCtD
Zolmitriptan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000405	CcSEcCtD
Zolmitriptan—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000405	CcSEcCtD
Zolmitriptan—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000405	CcSEcCtD
Zolmitriptan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000405	CcSEcCtD
Zolmitriptan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000403	CcSEcCtD
Zolmitriptan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000402	CcSEcCtD
Zolmitriptan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.000402	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000402	CcSEcCtD
Zolmitriptan—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000401	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000166	0.00539	CbGpPWpGaD
Zolmitriptan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000399	CcSEcCtD
Zolmitriptan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000399	CcSEcCtD
Zolmitriptan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000398	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000165	0.00535	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000397	CcSEcCtD
Zolmitriptan—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.000396	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000163	0.00531	CbGpPWpGaD
Zolmitriptan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000393	CcSEcCtD
Zolmitriptan—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000392	CcSEcCtD
Zolmitriptan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000392	CcSEcCtD
Zolmitriptan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000391	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000162	0.00525	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00039	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.00039	CcSEcCtD
Zolmitriptan—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000389	CcSEcCtD
Zolmitriptan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000389	CcSEcCtD
Zolmitriptan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000389	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000387	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00016	0.0052	CbGpPWpGaD
Zolmitriptan—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000386	CcSEcCtD
Zolmitriptan—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000386	CcSEcCtD
Zolmitriptan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000381	CcSEcCtD
Zolmitriptan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.00038	CcSEcCtD
Zolmitriptan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000376	CcSEcCtD
Zolmitriptan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000376	CcSEcCtD
Zolmitriptan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.000376	CcSEcCtD
Zolmitriptan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000374	CcSEcCtD
Zolmitriptan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000374	CcSEcCtD
Zolmitriptan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000374	CcSEcCtD
Zolmitriptan—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000372	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000154	0.00499	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000154	0.00499	CbGpPWpGaD
Zolmitriptan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000371	CcSEcCtD
Zolmitriptan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000371	CcSEcCtD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000153	0.00498	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000369	CcSEcCtD
Zolmitriptan—Headache—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000368	CcSEcCtD
Zolmitriptan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000367	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000152	0.00492	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000364	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00015	0.00488	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00015	0.00488	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00015	0.00488	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000362	CcSEcCtD
Zolmitriptan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000359	CcSEcCtD
Zolmitriptan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000357	CcSEcCtD
Zolmitriptan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000357	CcSEcCtD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000147	0.00477	CbGpPWpGaD
Zolmitriptan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000353	CcSEcCtD
Zolmitriptan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000353	CcSEcCtD
Zolmitriptan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000352	CcSEcCtD
Zolmitriptan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.00035	CcSEcCtD
Zolmitriptan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.00035	CcSEcCtD
Zolmitriptan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000349	CcSEcCtD
Zolmitriptan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000349	CcSEcCtD
Zolmitriptan—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000348	CcSEcCtD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000144	0.00468	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000144	0.00468	CbGpPWpGaD
Zolmitriptan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000348	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000144	0.00467	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000142	0.00462	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000141	0.00457	CbGpPWpGaD
Zolmitriptan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00034	CcSEcCtD
Zolmitriptan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000338	CcSEcCtD
Zolmitriptan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000336	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000139	0.00452	CbGpPWpGaD
Zolmitriptan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000335	CcSEcCtD
Zolmitriptan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000335	CcSEcCtD
Zolmitriptan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000335	CcSEcCtD
Zolmitriptan—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000333	CcSEcCtD
Zolmitriptan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000333	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000138	0.00447	CbGpPWpGaD
Zolmitriptan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00033	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000135	0.00438	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000135	0.00437	CbGpPWpGaD
Zolmitriptan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000325	CcSEcCtD
Zolmitriptan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000324	CcSEcCtD
Zolmitriptan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000324	CcSEcCtD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000134	0.00434	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000132	0.0043	CbGpPWpGaD
Zolmitriptan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000319	CcSEcCtD
Zolmitriptan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000316	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00013	0.00421	CbGpPWpGaD
Zolmitriptan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000313	CcSEcCtD
Zolmitriptan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000313	CcSEcCtD
Zolmitriptan—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00031	CcSEcCtD
Zolmitriptan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00031	CcSEcCtD
Zolmitriptan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000309	CcSEcCtD
Zolmitriptan—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000308	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000125	0.00407	CbGpPWpGaD
Zolmitriptan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000301	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000124	0.00404	CbGpPWpGaD
Zolmitriptan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000299	CcSEcCtD
Zolmitriptan—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000298	CcSEcCtD
Zolmitriptan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000298	CcSEcCtD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000123	0.00399	CbGpPWpGaD
Zolmitriptan—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000296	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000122	0.00396	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000122	0.00396	CbGpPWpGaD
Zolmitriptan—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000292	CcSEcCtD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00012	0.00391	CbGpPWpGaD
Zolmitriptan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000287	CcSEcCtD
Zolmitriptan—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000285	CcSEcCtD
Zolmitriptan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000284	CcSEcCtD
Zolmitriptan—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000283	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000117	0.0038	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000117	0.0038	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000117	0.0038	CbGpPWpGaD
Zolmitriptan—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000281	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000115	0.00372	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00372	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000115	0.00372	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00372	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000114	0.00372	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000114	0.00371	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000112	0.00363	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000111	0.00362	CbGpPWpGaD
Zolmitriptan—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000268	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00011	0.00359	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00011	0.00357	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00011	0.00356	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000109	0.00354	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000106	0.00343	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000106	0.00343	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000105	0.00342	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TAT—acquired immunodeficiency syndrome	0.000104	0.00338	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000103	0.00336	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000103	0.00336	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000103	0.00336	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000103	0.00335	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000103	0.00334	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000103	0.00333	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000101	0.00329	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.98e-05	0.00324	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	9.88e-05	0.00321	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.55e-05	0.0031	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.39e-05	0.00305	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.39e-05	0.00305	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.28e-05	0.00301	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.17e-05	0.00298	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	9.13e-05	0.00296	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.9e-05	0.00289	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AGPS—acquired immunodeficiency syndrome	8.86e-05	0.00288	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.72e-05	0.00283	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.72e-05	0.00283	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.72e-05	0.00283	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.71e-05	0.00283	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.52e-05	0.00277	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.31e-05	0.0027	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.02e-05	0.0026	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.86e-05	0.00255	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.85e-05	0.00255	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.85e-05	0.00255	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.75e-05	0.00252	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.71e-05	0.0025	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.34e-05	0.00238	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.14e-05	0.00232	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.08e-05	0.0023	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.06e-05	0.00229	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.03e-05	0.00228	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.03e-05	0.00228	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.91e-05	0.00225	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.88e-05	0.00224	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	6.79e-05	0.0022	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.75e-05	0.00219	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.75e-05	0.00219	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.65e-05	0.00216	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	6.65e-05	0.00216	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.64e-05	0.00216	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.61e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.61e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.61e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.61e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.52e-05	0.00212	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.47e-05	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.47e-05	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.43e-05	0.00209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.38e-05	0.00207	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.25e-05	0.00203	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.1e-05	0.00198	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6e-05	0.00195	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6e-05	0.00195	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.98e-05	0.00194	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.98e-05	0.00194	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.9e-05	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.88e-05	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.88e-05	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	5.77e-05	0.00187	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.55e-05	0.0018	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.55e-05	0.0018	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	5.48e-05	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.27e-05	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.24e-05	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.04e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.04e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.03e-05	0.00163	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.95e-05	0.00161	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.93e-05	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.93e-05	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.92e-05	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.85e-05	0.00158	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.76e-05	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	4.66e-05	0.00151	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.57e-05	0.00148	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.55e-05	0.00148	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.53e-05	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.5e-05	0.00146	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.48e-05	0.00145	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.48e-05	0.00145	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.47e-05	0.00145	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.44e-05	0.00144	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.4e-05	0.00143	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.22e-05	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.17e-05	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.16e-05	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.11e-05	0.00134	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.09e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.08e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.03e-05	0.00131	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.84e-05	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.8e-05	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.77e-05	0.00122	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.75e-05	0.00122	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.72e-05	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.69e-05	0.0012	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.69e-05	0.0012	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.55e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.55e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.47e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.47e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.41e-05	0.00111	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.38e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.36e-05	0.00109	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.27e-05	0.00106	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.11e-05	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.07e-05	0.000997	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.81e-05	0.000914	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.7e-05	0.000876	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.66e-05	0.000863	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.65e-05	0.000859	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.65e-05	0.000859	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.64e-05	0.000858	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.62e-05	0.00085	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.6e-05	0.000845	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.56e-05	0.000832	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.43e-05	0.000789	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.38e-05	0.000773	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.38e-05	0.000772	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.33e-05	0.000756	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.2e-05	0.000713	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.18e-05	0.00071	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.000654	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.000644	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.95e-05	0.000634	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—acquired immunodeficiency syndrome	1.82e-05	0.00059	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.81e-05	0.000589	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.77e-05	0.000576	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.5e-05	0.000489	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.4e-05	0.000456	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.4e-05	0.000454	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000447	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.37e-05	0.000444	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.29e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.00034	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000338	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.25e-06	0.000268	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.08e-06	0.000262	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.7e-06	0.000218	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.16e-06	0.0002	CbGpPWpGaD
